Skip to main content
. 2021 Mar 25;51(6):504–514. doi: 10.4070/kcj.2020.0448

Table 5. Comparative outcomes of prosthetic versus native groups.

Variables Prosthetic (n=56) Native (n=213) OR/HR 95% CI p value
Early outcomes*
Early mortality (<30 days) 8 (14.3) 13 (6.1) 2.56 0.97–6.44 0.049
LCOS requiring mechanical support 7 (12.5) 8 (3.8) 3.66 1.23–10.68 0.017
Early stroke 7 (12.5) 18 (8.5) 1.55 0.57–3.77 0.356
New-onset dialysis 11 (19.6) 14 (6.6) 3.47 1.45–8.15 0.004
Reoperation for bleeding 8 (14.3) 7 (3.3) 4.90 1.69–14.63 0.003
Early PPM implantation 7 (12.5) 3 (1.4) 10.0 2.68–47.68 0.001
Overall outcomes
Overall mortality 22 (22.4) 34 (3.6) 2.97 1.73–5.10 <0.001
Valve reinfection 5 (5.1) 2 (0.2) 14.05 2.72–72.68 0.002
Stroke 10 (10.2) 25 (2.7) 1.82 0.87–3.81 0.110
Valve reoperation 2 (2.0) 11 (1.2) 0.86 0.19–3.88 0.845
PPM implantation 8 (8.1) 5 (0.5) 8.35 2.67–26.18 <0.001

*Early outcomes are given as OR and long-term outcomes are given as HR derived from univariable logistic regression and Cox-proportional hazard model, respectively. Overall outcomes are presented as number of patients (number/100 patients-year).

CI = confidence interval; HR = hazard ratio; LCOS = low cardiac output syndrome; OR = odds ratio; PPM = permanent pacemaker.